Jun 04, 2019 / 12:30PM GMT
Peter James Welford - Jefferies LLC, Research Division - Senior Equity Analyst
Good morning. My name is Peter Welford, I'm the European biopharma and life sciences analyst at Jefferies in London. And it's my great pleasure to introduce the next company in this track, which is QIAGEN. And it's my great pleasure to have here from QIAGEN today, Peer Schatz, CEO; and Jonathan Arnold as well. Jonathan Arnold (inaudible) I say that he runs Precision Diagnostics, I believe, and results for QIAGEN as well. So it's a fireside chat. I've obviously got questions. Please do raise the hand and actually we'll put over a mic somewhere around here, we'll get a mic out to you as well and happy then by all means for anyone to take any questions from the audience. So with that, over to Peer, and thank you very much.
Peer Michael Schatz - QIAGEN N.V. - CEO, MD & Member of Management Board
Well, thanks, Peter. It's a pleasure to be here. We just came from ASCO, which is the largest cancer conference in the world, 50,000 oncologists swarmed in on Chicago once a year, and it has
Qiagen NV at Jefferies Healthcare Conference Transcript
Jun 04, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers